BioLineRx (BLRX) Net Income (2010 - 2026)
BioLineRx's Net Income was -$4.34 million in the quarter ended Jun 30, 2026, compared with -$3.94 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Net Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioLineRx's Net Income was -$11.21 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$2.03 million.
- In earlier years, Net Income was -$9.22 million in the year ended Dec 31, 2024, -$60.61 million in the year ended Dec 31, 2023, -$24.95 million in the year ended Dec 31, 2022 and -$27.05 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Net Income since the quarter ended Dec 31, 2023.
- Per Business Quant data, BLRX's Net Income in the three quarters before the quarter ended Jun 30, 2026 was -$2.55 million (quarter ended Mar 31, 2026), -$2.8 million (quarter ended Dec 31, 2025) and -$1.53 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -248.00 Mn |
| 10 | BioLineRx | 8.53 Mn | -67.99 Mn | 235,000.00 | -4.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.34 Mn |
| Mar 31, 2026 | -2.55 Mn |
| Dec 31, 2025 | -5.36 Mn |
| Sep 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -3.94 Mn |
| Mar 31, 2025 | -1.68 Mn |
| Dec 31, 2024 | -3.19 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | -696,000.00 |
| Dec 31, 2023 | -13.88 Mn |
| Sep 30, 2023 | -16.02 Mn |
| Jun 30, 2023 | -18.55 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -5.73 Mn |
| Sep 30, 2022 | -6.85 Mn |
| Jun 30, 2022 | -7.44 Mn |
| Mar 31, 2022 | -4.93 Mn |
| Dec 31, 2021 | -4.30 Mn |
| Sep 30, 2021 | -5.72 Mn |
API Access
BioLineRx Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();